{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:24:48Z","timestamp":1787030688432,"version":"build-2736575974"},"reference-count":84,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.3892\/ijmm.2015.2397","type":"journal-article","created":{"date-parts":[[2015,10,30]],"date-time":"2015-10-30T02:45:15Z","timestamp":1446173115000},"page":"11-20","source":"Crossref","is-referenced-by-count":82,"title":["Characteristics of \u03b1-Gal epitope, anti-Gal antibody, \u03b11,3 galactosyltransferase and its clinical exploitation (Review)"],"prefix":"10.3892","volume":"37","author":[{"given":"GUOLI","family":"HUAI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PING","family":"QI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HONGJI","family":"YANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YI","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,10,30]]},"reference":[{"key":"key20180107234541_b1-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"28310","DOI":"10.1074\/jbc.M202631200","article-title":"Structural basis of ordered binding of donor and acceptor substrates to the retaining glycosyltransferase, alpha-1,3-galacto-syltransferase","volume":"277","author":"Boix","year":"2002","journal-title":"J Biol Chem"},{"key":"key20180107234541_b2-ijmm-37-01-0011","first-page":"543","article-title":"The expression and distribution of \u03b1-Gal gene in various species ocular surface tissue","volume":"5","author":"Shao","year":"2012","journal-title":"Int J Ophthalmol"},{"key":"key20180107234541_b3-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1440-1711.2005.01366.x","article-title":"The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy","volume":"83","author":"Galili","year":"2005","journal-title":"Immunol Cell Biol"},{"key":"key20180107234541_b4-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"12927","DOI":"10.1016\/S0021-9258(17)38814-2","article-title":"Biosynthesis of terminal Gal alpha 1\u21923Gal beta 1\u21924GlcNAc-R oligosaccharide sequences on glycoconjugates. Purification and acceptor specificity of a UDP-Gal:N-acetyllactosaminide alpha 1\u21923-galactosyltrans-ferase from calf thymus","volume":"260","author":"Blanken","year":"1985","journal-title":"J Biol Chem"},{"key":"key20180107234541_b5-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/glycob\/cwg030","article-title":"Characterization of the rat alpha(1,3)galactosyltransferase: evidence for two independent genes encoding glycosyltransferases that synthesize Galalpha(1,3)Gal by two separate glycosylation pathways","volume":"13","author":"Taylor","year":"2003","journal-title":"Glycobiology"},{"key":"key20180107234541_b6-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"6991","DOI":"10.1016\/S0021-9258(20)89600-8","article-title":"Characterization of an alpha 1\u21923-galactosyltransferase homologue on human chromosome 12 that is organized as a processed pseudogene","volume":"266","author":"Joziasse","year":"1991","journal-title":"J Biol Chem"},{"key":"key20180107234541_b7-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"e1000112","DOI":"10.1371\/journal.pbio.1000112","article-title":"Mouse Genome Sequencing Consortium: Lineage-specific biology revealed by a finished genome assembly of the mouse","volume":"7","author":"Church","year":"2009","journal-title":"PLoS Biol"},{"key":"key20180107234541_b8-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00182319","article-title":"cDNA sequence and chromosome localization of pig alpha 1,3 galactosyltransferase","volume":"41","author":"Strahan","year":"1995","journal-title":"Immunogenetics"},{"key":"key20180107234541_b9-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"R42","DOI":"10.1186\/gb-2009-10-4-r42","article-title":"A whole-genome assembly of the domestic cow, Bos taurus","volume":"10","author":"Zimin","year":"2009","journal-title":"Genome Biol"},{"key":"key20180107234541_b10-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nature04338","article-title":"Genome sequence, comparative analysis and haplotype structure of the domestic dog","volume":"438","author":"Lindblad-Toh","year":"2005","journal-title":"Nature"},{"key":"key20180107234541_b11-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/35057062","article-title":"International Human Genome Sequencing Consortium: Initial sequencing and analysis of the human genome","volume":"409","author":"Lander","year":"2001","journal-title":"Nature"},{"key":"key20180107234541_b12-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF00201098","article-title":"Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody","volume":"15","author":"Galili","year":"1993","journal-title":"Springer Semin Immunopathol"},{"key":"key20180107234541_b13-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"7055","DOI":"10.1016\/S0021-9258(19)39258-0","article-title":"Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UDP-Gal:beta-D-G al(1,4)-D-GlcNAc alpha(1,3)-galactosyltransferase cDNA","volume":"265","author":"Larsen","year":"1990","journal-title":"J Biol Chem"},{"key":"key20180107234541_b14-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"8317","DOI":"10.1128\/JVI.01118-13","article-title":"Possible role of a cell surface carbohydrate in evolution of resistance to viral infections in old world primates","volume":"87","author":"Rodriguez","year":"2013","journal-title":"J Virol"},{"key":"key20180107234541_b15-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.imlet.2015.02.001","article-title":"Anti-Gal IgM, IgA and IgG natural antibodies in childhood","volume":"164","author":"Hamanova","year":"2015","journal-title":"Immunol Lett"},{"key":"key20180107234541_b16-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.4049\/jimmunol.155.3.1276","article-title":"Human anti-Gal heavy chain genes. Preferential use of VH3 and the presence of somatic mutations","volume":"155","author":"Wang","year":"1995","journal-title":"J Immunol"},{"key":"key20180107234541_b17-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11882-012-0315-y","article-title":"Delayed anaphylaxis to red meat in patients with IgE specific for galactose alpha-1,3-ga-lactose (alpha-gal)","volume":"13","author":"Commins","year":"2013","journal-title":"Curr Allergy Asthma Rep"},{"key":"key20180107234541_b18-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/00007890-199804270-00020","article-title":"A sensitive assay for measuring alpha-Gal epitope expression on cells by a monoclonal anti-Gal antibody","volume":"65","author":"Galili","year":"1998","journal-title":"Transplantation"},{"key":"key20180107234541_b19-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1399-3089.1998.tb00027.x","article-title":"Adult and neonatal anti-Gal response in knock-out mice for alpha1,3galactosyltransferase","volume":"5","author":"LaTemple","year":"1998","journal-title":"Xenotransplantation"},{"key":"key20180107234541_b20-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.3346\/jkms.2009.24.6.1126","article-title":"Removal of alpha-Gal epitopes from porcine aortic valve and pericardium using recombinant human alpha galactosidase A","volume":"24","author":"Park","year":"2009","journal-title":"J Korean Med Sci"},{"key":"key20180107234541_b21-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"9131","DOI":"10.1128\/JVI.00647-07","article-title":"Immunogenicity of influenza virus vaccine is increased by anti-gal-mediated targeting to antigen-presenting cells","volume":"81","author":"Abdel-Motal","year":"2007","journal-title":"J Virol"},{"key":"key20180107234541_b22-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nature07039","article-title":"Wound repair and regeneration","volume":"453","author":"Gurtner","year":"2008","journal-title":"Nature"},{"key":"key20180107234541_b23-ijmm-37-01-0011","first-page":"3069","article-title":"Synthesis of alpha-galactosyl epitopes by recombinant alpha1,3galactosyl transferase for opsonization of human tumor cell vaccines by anti-galactose","volume":"56","author":"LaTemple","year":"1996","journal-title":"Cancer Res"},{"key":"key20180107234541_b24-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1056\/NEJM199909023411006","article-title":"Cutaneous wound healing","volume":"341","author":"Singer","year":"1999","journal-title":"N Engl J Med"},{"key":"key20180107234541_b25-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2741\/A220","article-title":"Transgenic approaches for the reduction of Galalpha(1,3)Gal for xenotransplantation","volume":"2","author":"Sandrin","year":"1997","journal-title":"Front Biosci"},{"key":"key20180107234541_b26-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"33105","DOI":"10.1074\/jbc.271.51.33105","article-title":"Switching amino-terminal cytoplasmic domains of alpha(1,2) fucosyltransferase and alpha(1,3)galactosyltransferase alters the expression of H substance and Galalpha(1,3)Gal","volume":"271","author":"Osman","year":"1996","journal-title":"J Biol Chem"},{"key":"key20180107234541_b27-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/sj.cr.7290076","article-title":"Adenovirus-mediated expression of pig alpha(1,3) galactosyltransferase reconstructs Gal alpha(1, 3) gal epitope on the surface of human tumor cells","volume":"11","author":"Xing","year":"2001","journal-title":"Cell Res"},{"key":"key20180107234541_b28-ijmm-37-01-0011","first-page":"145","article-title":"Cloning of splicing variants of alpha1,3-galactosyltransferase cDNA of Chinese Banna Minipig inbred line and its expression in human cells","volume":"43","author":"Liu","year":"2012","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"key20180107234541_b29-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"14290","DOI":"10.1016\/S0021-9258(18)71676-1","article-title":"Bovine alpha 1\u21923-galactosyltransferase: Isolation and characterization of a cDNA clone. Identification of homologous sequences in human genomic DNA","volume":"264","author":"Joziasse","year":"1989","journal-title":"J Biol Chem"},{"key":"key20180107234541_b30-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/glycob\/cwf087","article-title":"A complete alpha1,3-galactosyltransferase gene is present in the human genome and partially transcribed","volume":"12","author":"Lant\u00e9ri","year":"2002","journal-title":"Glycobiology"},{"key":"key20180107234541_b31-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"7401","DOI":"10.1073\/pnas.88.16.7401","article-title":"Gene sequences suggest inactivation of alpha-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys","volume":"88","author":"Galili","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107234541_b32-ijmm-37-01-0011","first-page":"231","article-title":"Human xenoreactivity is reduced in mice bearing porcine antisense alpha(1,3) galactosyltransferase cDNA","volume":"22","author":"Ma","year":"2001","journal-title":"Acta Pharmacol Sin"},{"key":"key20180107234541_b33-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1006\/jhev.1995.1067","article-title":"Suppression of a-galactosyl epitopes synthesis and production of the natural anti-Gal antibody: A major evolutionary event in ancestral Old World primates","volume":"29","author":"Galili","year":"1995","journal-title":"J Hum Evol"},{"key":"key20180107234541_b34-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1399-3089.2012.00710.x","article-title":"Anti-gal antibodies in \u03b11,3-galactosyltransferase gene-knockout pigs","volume":"19","author":"Fang","year":"2012","journal-title":"Xenotransplantation"},{"key":"key20180107234541_b35-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"10114","DOI":"10.1074\/jbc.M110527200","article-title":"Molecular basis of evolutionary loss of the alpha 1,3-galac-tosyltransferase gene in higher primates","volume":"277","author":"Koike","year":"2002","journal-title":"J Biol Chem"},{"key":"key20180107234541_b36-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"11391","DOI":"10.1073\/pnas.90.23.11391","article-title":"Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1\u20133) Gal epitopes","volume":"90","author":"Sandrin","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107234541_b37-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1084\/jem.160.5.1519","article-title":"A unique natural human IgG antibody with anti-a-galactosyl specificity","volume":"160","author":"Galili","year":"1984","journal-title":"J Exp Med"},{"key":"key20180107234541_b38-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/imm.12110","article-title":"Anti-Gal: An abundant human natural antibody of multiple pathogeneses and clinical benefits","volume":"140","author":"Galili","year":"2013","journal-title":"Immunology"},{"key":"key20180107234541_b39-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00239-014-9652-x","article-title":"Significance of the evolutionary \u03b11,3-galacto-syltransferase (GGTA1) gene inactivation in preventing extinction of apes and old world monkeys","volume":"80","author":"Galili","year":"2015","journal-title":"J Mol Evol"},{"key":"key20180107234541_b40-ijmm-37-01-0011","first-page":"231","article-title":"Human xeno-reactivity is reduced in mice bearing porcine antisense alpha(1,3) galactosyltransferase cDNA","volume":"22","author":"Ma","year":"2001","journal-title":"Acta Pharmacol Sin"},{"key":"key20180107234541_b41-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/hep.1840070324","article-title":"Modulation of the immunological response to hepatitis B virus by antibodies","volume":"7","author":"Celis","year":"1987","journal-title":"Hepatology"},{"key":"key20180107234541_b42-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/TP.0b013e318203c27d","article-title":"Identification of new carbohydrate and membrane protein antigens in cardiac xenotransplantation","volume":"91","author":"Byrne","year":"2011","journal-title":"Transplantation"},{"key":"key20180107234541_b43-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/0167-5699(93)90261-I","article-title":"Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: A major obstacle for xenotransplan-tation in humans","volume":"14","author":"Galili","year":"1993","journal-title":"Immunol Today"},{"key":"key20180107234541_b44-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/jme.2005.012914","article-title":"Xenotransplantation: A bioethical evaluation","volume":"32","author":"Anderson","year":"2006","journal-title":"J Med Ethics"},{"key":"key20180107234541_b45-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/ejcts\/ezr260","article-title":"Immune response to bovine pericardium implanted into \u03b11,3-galactosyltransferase knockout mice: feasibility as an animal model for testing efficacy of anticalcification treatments of xenografts","volume":"42","author":"Lee","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"key20180107234541_b46-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1002\/pmic.200700972","article-title":"Structural analysis of alpha-Gal and new non-Gal carbohydrate epitopes from specific pathogen-free miniature pig kidney","volume":"8","author":"Kim","year":"2008","journal-title":"Proteomics"},{"key":"key20180107234541_b47-ijmm-37-01-0011","first-page":"222","article-title":"Anti-alpha-Gal antibody response following xenogeneic heart valve implantation in adults","volume":"22","author":"Park","year":"2013","journal-title":"J Heart Valve Dis"},{"issue":"5329","key":"key20180107234541_b48-ijmm-37-01-0011","article-title":"Biomechanical properties of hybrid heart valve prosthesis utilizing the pigs that do not express the galactose-\u03b1-1,3-galactose (\u03b1-Gal) antigen derived tissue and tissue engineering technique","volume":"26","author":"Wilczek","year":"2015","journal-title":"J Mater Sci Mater Med"},{"key":"key20180107234541_b49-ijmm-37-01-0011","first-page":"387","article-title":"Elimination of alpha-gal xenoreactive epitope: Alpha-galactosidase treatment of porcine heart valves","volume":"21","author":"Choi","year":"2012","journal-title":"J Heart Valve Dis"},{"key":"key20180107234541_b50-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2362.2005.01441.x","article-title":"Alpha-Gal on bioprostheses: Xenograft immune response in cardiac surgery","volume":"35","author":"Konakci","year":"2005","journal-title":"Eur J Clin Invest"},{"key":"key20180107234541_b51-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.4049\/jimmunol.154.10.5500","article-title":"Cardiac xenografts between primate species provide evidence for the importance of the alpha-galactosyl determinant in hyperacute rejection","volume":"154","author":"Collins","year":"1995","journal-title":"J Immunol"},{"key":"key20180107234541_b52-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ahj.2012.05.011","article-title":"Porcine bioprosthetic heart valves: The next generation","volume":"164","author":"Manji","year":"2012","journal-title":"Am Heart J"},{"key":"key20180107234541_b53-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/TP.0b013e318212c7fe","article-title":"Comparison of Gal and non-Gal-mediated cardiac xenograft rejection","volume":"91","author":"Tazelaar","year":"2011","journal-title":"Transplantation"},{"key":"key20180107234541_b54-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1089\/ten.tea.2013.0062","article-title":"In vivo efficacy of alpha-galactosidase as possible promise for prolonged durability of bioprosthetic heart valve using alpha1,3-galactosyl-transferase knockout mouse","volume":"19","author":"Lim","year":"2013","journal-title":"Tissue Eng Part A"},{"key":"key20180107234541_b55-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jtcvs.2010.08.064","article-title":"Cardiac xenotransplantation technology provides materials for improved bioprosthetic heart valves","volume":"141","author":"McGregor","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key20180107234541_b56-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0029-1185395","article-title":"Alpha-Gal specific IgG immune response after implantation of bioprostheses","volume":"57","author":"Mangold","year":"2009","journal-title":"Thorac Cardiovasc Surg"},{"key":"key20180107234541_b57-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"380","DOI":"10.5090\/kjtcs.2012.45.6.380","article-title":"Changes of the structural and biomechanical properties of the bovine pericardium after the removal of \u03b1-Gal epitopes by decellularization and \u03b1-galactosidase treatment","volume":"45","author":"Nam","year":"2012","journal-title":"Korean J Thorac Cardiovasc Surg"},{"key":"key20180107234541_b58-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1089\/ten.2005.11.1274","article-title":"Presence and elimination of the xenoantigen gal (alpha1, 3) gal in tissue-engineered heart valves","volume":"11","author":"Kasimir","year":"2005","journal-title":"Tissue Eng"},{"key":"key20180107234541_b59-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jtcvs.2005.04.017","article-title":"Cardiac xenotransplantation: Recent preclinical progress with 3-month median survival","volume":"130","author":"McGregor","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key20180107234541_b60-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.4049\/jimmunol.176.4.2448","article-title":"The molecular basis for galalpha(1,3)gal expression in animals with a deletion of the alpha1,3galactosyltransferase gene","volume":"176","author":"Milland","year":"2006","journal-title":"J Immunol"},{"key":"key20180107234541_b61-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/MOT.0b013e328329250d","article-title":"Immune responses to alpha1,3 galactosyltransferase knockout pigs","volume":"14","author":"Puga Yung","year":"2009","journal-title":"Curr Opin Organ Transplant"},{"key":"key20180107234541_b62-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/01.tp.0000250598.29377.13","article-title":"Replacement of human anterior cruciate ligaments with pig ligaments: A model for anti-non-gal antibody response in long-term xenotransplantation","volume":"83","author":"Stone","year":"2007","journal-title":"Transplantation"},{"key":"key20180107234541_b63-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"65","DOI":"10.14348\/molcells.2015.2240","article-title":"Comparative N-linked glycan analysis of wild-type and \u03b11,3-galactosyltransferase gene knock-out pig fibroblasts using mass spectrometry approaches","volume":"38","author":"Park","year":"2015","journal-title":"Mol Cells"},{"key":"key20180107234541_b64-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbagen.2007.11.003","article-title":"The Galalpha1,3Galbeta1,4GlcNAc-R (alpha-Gal) epitope: A carbohydrate of unique evolution and clinical relevance","volume":"1780","author":"Macher","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"key20180107234541_b65-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/glycob\/12.2.135","article-title":"Expression of alpha-gal epitopes on HeLa cells transduced with adenovirus containing alpha1,3galactosyltransferase cDNA","volume":"12","author":"Deriy","year":"2002","journal-title":"Glycobiology"},{"key":"key20180107234541_b66-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/xen.12044","article-title":"First quantification of alpha-Gal epitope in current glutaraldehyde-fixed heart valve bioprostheses","volume":"20","author":"Naso","year":"2013","journal-title":"Xenotransplantation"},{"issue":"134020","key":"key20180107234541_b67-ijmm-37-01-0011","article-title":"Conversion of tumors into autologous vaccines by intra-tumoral injection of \u03b1-Gal glycolipids that induce anti-Gal\/\u03b1-Gal epitope interaction","volume":"2011","author":"Galili","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"key20180107234541_b68-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1126\/science.7513904","article-title":"Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens","volume":"264","author":"Huang","year":"1994","journal-title":"Science"},{"key":"key20180107234541_b69-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1084\/jem.173.1.37","article-title":"Effect of antigen\/antibody ratio on macrophage uptake, processing, and presentation to T cells of antigen complexed with polyclonal antibodies","volume":"173","author":"Manca","year":"1991","journal-title":"J Exp Med"},{"key":"key20180107234541_b70-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s00262-009-0662-2","article-title":"Intratumoral injection of alpha-gal glycolipids induces a protective anti-tumor T cell response which overcomes Treg activity","volume":"58","author":"Abdel-Motal","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"key20180107234541_b71-ijmm-37-01-0011","first-page":"819","article-title":"Depletion of naive T cells of the peripheral lymph nodes abrogates systemic antitumor protection conferred by IL-2 secreting cancer vaccines","volume":"3","author":"Schweighoffer","year":"1996","journal-title":"Gene Ther"},{"key":"key20180107234541_b72-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1006\/cimm.1996.0026","article-title":"Fc gamma RII on human B cells can mediate enhanced antigen presentation","volume":"167","author":"Liu","year":"1996","journal-title":"Cell Immunol"},{"key":"key20180107234541_b73-ijmm-37-01-0011","first-page":"3417","article-title":"Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase","volume":"59","author":"LaTemple","year":"1999","journal-title":"Cancer Res"},{"key":"key20180107234541_b74-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3892\/ijo.2014.2717","article-title":"Pancreatic cancer immunotherapy using a tumor lysate vaccine, engineered to express \u03b1-gal epitopes, targets pancreatic cancer stem cells","volume":"46","author":"Tanida","year":"2015","journal-title":"Int J Oncol"},{"key":"key20180107234541_b75-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/cas.12084","article-title":"Role of \u03b1-gal epitope\/anti-Gal antibody reaction in immunotherapy and its clinical application in pancreatic cancer","volume":"104","author":"Tanemura","year":"2013","journal-title":"Cancer Sci"},{"key":"key20180107234541_b76-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.1158\/0008-5472.CAN-09-4313","article-title":"Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: A novel approach to immunotherapy in pancreatic cancer","volume":"70","author":"Deguchi","year":"2010","journal-title":"Cancer Res"},{"key":"key20180107234541_b77-ijmm-37-01-0011","first-page":"3861","article-title":"Cancer immunotherapy by intratumoral injection of \u03b1-gal glyco-lipids","volume":"32","author":"Whalen","year":"2012","journal-title":"Anticancer Res"},{"key":"key20180107234541_b78-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0264-410X(95)00189-8","article-title":"Enhancement of antigen presentation of influenza virus hemagglutinin by the natural human anti-Gal antibody","volume":"14","author":"Galili","year":"1996","journal-title":"Vaccine"},{"key":"key20180107234541_b79-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0264-410X(96)00300-3","article-title":"Synthesis of alpha-gal epitopes on influenza virus vaccines, by recombinant alpha 1,3galactosyltransferase, enables the formation of immune complexes with the natural anti-Gal antibody","volume":"15","author":"Henion","year":"1997","journal-title":"Vaccine"},{"key":"key20180107234541_b80-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"6943","DOI":"10.1128\/JVI.00310-06","article-title":"Increased immunogenicity of human immunodeficiency virus gp120 engineered to express Galalpha1-3Galbeta1-4GlcNAc-R epitopes","volume":"80","author":"Abdel-Motal","year":"2006","journal-title":"J Virol"},{"key":"key20180107234541_b81-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/PRS.0b013e31823aebb1","article-title":"Accelerated porcine wound healing with a-Gal nanoparticles","volume":"129","author":"Hurwitz","year":"2012","journal-title":"Plast Reconstr Surg"},{"key":"key20180107234541_b82-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/xen.12034","article-title":"Discovery of the natural anti-Gal antibody and its past and future relevance to medicine","volume":"20","author":"Galili","year":"2013","journal-title":"Xenotransplantation"},{"key":"key20180107234541_b83-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.4049\/jimmunol.1002324","article-title":"Rapid recruitment and activation of macrophages by anti-Gal\/\u03b1-Gal liposome interaction accelerates wound healing","volume":"186","author":"Wigglesworth","year":"2011","journal-title":"J Immunol"},{"key":"key20180107234541_b84-ijmm-37-01-0011","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.burns.2009.04.002","article-title":"Accelerated healing of skin burns by anti-Gal\/alpha-gal liposomes interaction","volume":"36","author":"Galili","year":"2010","journal-title":"Burns"}],"container-title":["International Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijmm.2015.2397\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T23:47:00Z","timestamp":1718149620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijmm.2015.2397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,30]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,10,30]]},"published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.3892\/ijmm.2015.2397"],"URL":"https:\/\/doi.org\/10.3892\/ijmm.2015.2397","relation":{},"ISSN":["1107-3756","1791-244X"],"issn-type":[{"value":"1107-3756","type":"print"},{"value":"1791-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,30]]}}}